Merck’s WINREVAIR shows promise in phase 2 study for hard-to-treat pulmonary hypertension
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
The study successfully met its primary endpoint, demonstrating similar rates of viral suppression for DOR/ISL compared to Biktarvy at 48 weeks
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
Exemplifies commitment of Merck to energy efficiency and sustainable practices in high-performance computing by featuring advanced water-cooling systems and a hybrid cloud infrastructure
SOMA Color Mind is designed to simplify and accelerate color setup directly on the printing press
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
According to the ICMR-INDIAB study, 11.4% of adults in India have type 2 diabetes, while a staggering 15.3% are pre-diabetic
This is the first and only subcutaneous immune checkpoint inhibitor available in Europe
Subscribe To Our Newsletter & Stay Updated